The Accuracy of Fine Needle Aspiration Cytology and Flow Cytometry in Evaluation of Nodal and Extranodal Sites in Patients with Suspicion of Lymphoma by Petar Šenjug et al.
Coll. Antropol. 34 (2010) 1: 131–137
Original scientific paper
The Accuracy of Fine Needle Aspiration Cytology
and Flow Cytometry in Evaluation of Nodal and
Extranodal Sites in Patients with Suspicion of
Lymphoma
Petar [enjug1, Karmen Trutin Ostovi}2,5, Zorana Mileti}2,5, ^edna Tomasovi} Lon~ari}3, Tajana
[toos-Vei}2, Branimir Gizdi}4, Gordana Kai}2, Gorana Aralica1,3, Vlatko Pej{a1,4 and Ozren Jak{i}1,4
1 University of Zagreb, School of Medicine, Zagreb, Croatia
2 Department of Clinical Cytology and Cytometry, University Hospital Dubrava, Zagreb, Croatia
3 Department of Clinical and Experimental Pathology, University Hospital Dubrava, Zagreb, Croatia
4 Clinic of Internal Medicine, Department of Hematology, University Hospital Dubrava, Zagreb, Croatia
5 University of Applied Health Studies, Zagreb, Croatia
A B S T R A C T
Today lymphomas are defined according to a combination of morphology, immunophenotype, genetic features and
clinical presentation, so beside the pure cytomorphologic analysis in diagnosis of lymphoma ancillary techniques such as
cytochemistry, immunocytochemistry, molecular diagnosis and flow cytometry (FC) are often used. Our goal was to de-
terminate how is information given by fine-needle aspiration cytology (FNAC) and FC correlated with pathohistologic
diagnosis and to evaluate ability to diagnose and subclassify malignant lymphomas by FNAC and FC. This study is a
retrospective chart review of patients with suspicion of lymphoma processed at University Hospital Dubrava in Zagreb.
After analysis 50 patients fulfilled inclusion criteria for this study (FNAC diagnosis with or without FC and consecutive
confirmatory pathohistological diagnosis). When analyzing accuracy of FNAC according to suspicion of lymphoma or
NHL and differential diagnosis lymphoma sensitivity was 97.7%, specificity 85.7% and the diagnostic accuracy was
96%. When analyzing accuracy of FNAC according to the subclassification of lymphoma, sensitivity was 74.4%, specific-
ity 85.7% and the diagnostic accuracy 76%. Combined FNAC and FC improved sensitivity, positive predictive value, neg-
ative predictive value and diagnostic accuracy. Sensitivity was 79.1% and the diagnostic accuracy 80%. We have shown
that these methods can distinguish benign lymphadenopaties from lymphomas and also subclassify lymphomas and
quickly provide clinicians with that information.
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Introduction
Nowadays fine-needle aspiration cytology (FNAC) is
very often used as the first morphologic diagnostic proce-
dure for the diagnosis of malignant lymphoma1–3. Today
lymphomas are defined according to a combination of
morphology, immunophenotype, genetic features and cli-
nical presentation, so besides the cytomorphologic analy-
sis ancillary techniques such as cytochemistry, immuno-
cytochemistry, molecular tests (Southern blotting, the
polymerase chain reaction /PCR/, fluorescent in situ hy-
bridization /FISH/) and flow cytometry (FC) are often
used4. The role of the FNAC in diagnosis of Hodgkin’s
lymphoma (HL) and non-Hodgkin’s lymphoma (NHL)
was often stated as controversial5–7. At first FNAC was
mainly used to diagnose recurrent disease or for staging
purposes8. The main controversy about the FNAC was
its value in the primary diagnosis of lymphoma9,10. A
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large amount of published articles has shown the value of
FNAC in the diagnosis and classification of lymphomas
especially when FNAC was combined with other diagnos-
tic techniques such as flow cytometry or other immuno-
phenotypic procedures1,6,9,11–15.
The FNAC and FC are complementary diagnostic pro-
cedures which play crucial role in the initial lymphoma
diagnosing triage. University Hospital Dubrava is rare
case in Croatia where FNAC and FC are situated at the
same department (Department of Clinical Cytology and
Cytometry). Both FNAC and FC are used for triaging be-
nign from malignant lymphadenopathies but FC is not
preformed in all cases. Considering clinical presentation
and cytological findings a cytologist indicates FC analy-
sis. FC analysis is used as an ancillary technique with
purpose of distinguishing malignant from benign lym-
phadenopaties and classification of non Hodgkin’s lym-
phomas. With this kind of organization the use of mo-
noclonal antibodies used in FC is being rationalized. In
this retrospective review we have analyzed the role of
FNAC and FC in comparison to pathohistologic analysis.
Our goal was to determinate how is the information
given by FNAC and FC correlated with the pathohi-
stologic diagnosis, to evaluate ability to diagnose and
subclassify malignant lymphomas by FNAC and FC and
to discover possible advantages or limitations of these
procedures.
Patients and Methods
This study is a retrospective chart review of patients
with suspicion of lymphoma processed at University Hos-
pital Dubrava in Zagreb. We reviewed patient’s charts at
the Department of Clinical and Experimental Pathology
and the Department of Clinical Cytology and Cytometry
within two years and two months (from March 2007 to
May 2009). In this study only patients with suspicion of
lymphoma who underwent procedure of FNAC (with or
without FC) and at the same time had consecutive confir-
matory pathohistological diagnosis were included.
Patients were first identified by searching the archive
of the Department of Clinical and Experimental Pathol-
ogy for Lymphoid Lesions. Patients with diagnosis of HL,
NHL and benign lymphadenopathy were included in the
study. Patients with diagnosis of carcinoma, melanoma
and other solid tumors were excluded from analysis as
well as the patients with previously diagnosis of lym-
phoma. Tissue samples were lymph nodes and extra-
nodal sites. After identifying 88 patients with patho-
histological diagnosis we analyzed the archive of the
Department of Clinical Cytology and Cytometry to iden-
tify which of those patients underwent procedure of
FNAC and on which of those samples was FC also pre-
formed. We found 50 patients that underwent the proce-
dure of FNACwith or without FC, so 38 patients were ex-
cluded from the study. Results were compared for all
patients who underwent procedure of FNAC (with or
without FC) and at the same time had consecutive confir-
matory pathohistological diagnosis.
Pathohistological diagnoses were made by two pathol-
ogists from the Department of Clinical and Experimental
Pathology and the cytological diagnoses were made by
three cytologists from the Department of Clinical Cytol-
ogy and Cytometry. FC was preformed by a biologist from
the Department of Clinical Cytology and Cytometry.
All the calculations in this study, including sensitivity,
specificity, positive predictive value, negative predictive
value and the diagnostic accuracy were manually com-
puted. None specific statistical computer software was
used.
Results
After analyzing the archive of Department of Pathol-
ogy we found 88 patients with lymphoma and benign
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Submandibular salivatory gland 1
Confirmatory pathohistological diagnoses
B-cell chronic lymphocytic leukemia/small
lymphocytic lymphoma
2







Mantle cell lymphoma 5
Diffuse large B-cell lymphoma 16
T-lymphoblastic lymphoma/leukemia 1
Anaplastic large cell lymphoma 3
High grade non-Hodgkin’s lymphoma 1
Hodgkin’s lymphoma 8
Benign lympadenopathy 7
lymphadenopathies. Samples were taken from nodal and
extranodal sites. After analysis and comparison with the
archive of the Department of Clinical Cytology and Cy-
tometry, 50 patients fulfilled inclusion criteria for this
study (FNAC diagnosis with or without FC and consecu-
tive confirmatory pathohistological diagnosis). All of 50
patients were analyzed for the fist time for suspicion of
lymphoma so all of the lymphoma diagnoses were pri-
mary. Recurrent patients were excluded from the analy-
sis. Age of the patients ranged from 25 to 83 years, with
the median of 53.5 years. There were 27 (54%) male and
23 (46%) female patients. The most frequent samples for
the analysis were lymph nodes (42 out of 50, 84%) and
the biopsy of soft tissue (4 out of 50, 8%). Pathohisto-
logical diagnoses were made according to WHO classifi-
cation of lymphomas4. The most frequent diagnosis was
diffuse large B-cell lymphoma (DLBCL) (16 out of 50,
32%) followed by HL (8 out of 50, 16%), follicular lym-
phoma (FCL) (6 out of 50, 12%) and mantle cell lym-
phoma (MCL) (5 out of 50, 10%). One sample was classi-
fied as high grade non-Hodgkin’s lymphoma. Seven
specimens (14%) were pathohistologically diagnosed as
benign. Table 1 summarizes our patients’ characteris-
tics.
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TABLE 2












Diagnosis of Lymphoma (FNAC) 97.7 85.7 97.7 85.7 96
Subclasiffication of lymphoma (FNAC) 74.4 85.7 97 35.3 76
Subclassification of lymphoma (FNAC + FC) 79.1 85.7 97.1 40 80
FNAC – fine needle aspiration cytology, FC – Flow cytometry
TABLE 3
COMPARISON OF FINE-NEEDLE ASPIRATION CYTOLOGY (FNAC) AND PATHOHISTOLOGIC DIAGNOSIS
Pathohistological diagnosis
FNAC diagnosis CLL/SLL SMZL FCL MCL DLBCL T-LBL ALCL Hg NHL HL Benign Total
CLL /SLL 1 1
FCL 4 1 5
MCL 1 1
SMZL 1 1
Large B-cell NHL 1* 11 12
LBL 1 1
ALCL 2 1 3
High grade NHL 1 1
Low grade NHL 1 1 2
Small cell NHL 1* 1 2
NHL 1 1 1 3
Chronic lymphoproliferative disease 1 1 2
Suspicious NHL 1 1





Malignant tumor 1 1
Benign 6 6
Total 2 1 6 5 16 1 3 1 8 7 50
*immunophenotype suggested MCL characteristics, CLL/SLL – B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,
SMZL – Splenic marginal zone B-cell lymphoma, FCL – Follicular lymphoma, MCL – Mantle cell lymphoma, DLBCL – Diffuse large
B-cell lymphoma, T-LBL – Precursor T-lymphoblastic lymphoma/leukemia, ALCL – Anaplastic large cell lymphoma, Hg NHL – High
grade non-Hodgkin’s lymphoma, HL – Hodgkin’s lymphoma, NHL – non-Hodgkin’s lymphoma, LBL – Lymphoblastic lymphoma,
FNAC – fine needle aspiration cytology
Comparison of pathohistological and FNAC
analysis
The most common diagnosis by the FNAC was a large
B-cell non-Hodgkin’s lymphoma (12 out of 50, 24%) fol-
lowed by HL (6 out of 50, 12%), benign lymphadenopathy
(6 out of 50, 12%) and FCL (5 out of 50, 10%). There was
no case pathohistologically diagnosed as lymphoma that
was diagnosed benign by the FNAC. Nevertheless, there
was one case pathohistologically diagnosed as benign
that was stated by the FNAC as suspicious of NHL.
When analyzing accuracy of FNAC according to the sus-
picion of lymphoma or NHL and the differential diagno-
sis lymphoma, sensitivity was 97.7%, specificity 85.7%
and the diagnostic accuracy was 96%. When analyzing
accuracy of FNAC according to the subclassification of
lymphoma, sensitivity was 74.4%, specificity 85.7% and
the diagnostic accuracy 76% as shown in table 2. One
case of B-cell chronic lymphocytic leukemia/small lym-
phocytic lymphoma (CLL/SLL) was stated by FNAC as
CLL/SLL and one as chronic lymphoproliferative dis-
ease. There was only one case of splenic marginal zone
B-cell lymphoma (SMZL) and it was stated as SMZL.
Four out of six (66.7%) of the FCLs were diagnosed as the
FCLs, one was stated as NHL and one was stated as
chronic lymphoproliferaive disease. One out of five (20%)
MCLs was classified as the MCL, other four were stated
as large B-cell NHL, low grade NHL, small cell NHL and
NHL (not specified). Eleven out of sixteen (68.7%) DLBCLs
were classified as large B-cell lymphomas and in one case
DLBCL was classified as FCL, high grade NHL, small
cell NHL, NHL (not specified) and malignant tumor. One
T-cell lymphoblastic lymphoma (T-LBL) was correctly di-
agnosed as the lymphoblastic lymphoma. Anaplastic lar-
ge cell lymphoma (ALCL) was twice classified correctly
(66.7%) and was once stated as a malignant tumor with
differential diagnosis of lymphoma. One result pathologi-
cally diagnosed as high grade NHL was cytologically di-
agnosed as low grade NHL. Six out of eight cases (75%) of
HLs were classified correctly, one was classified as ALCL
and one was classified as suspicious of lymphoma. Six out
of seven (85.7%) benign lymphadenopathies were cyto-
logically classified as benign and one (14.3%) was stated
as suspicious of NHL. Table 3 shows comparison of
pathohistological and FNAC analysis.
Comparison of pathohistological and FC analysis
FC analysis was performed on 44 (88%) patients in
our study. Table 4 shows the comparison of pathohisto-
logical and FC analysis. All of B-cell non Hodgkin’s lym-
phomas were stated as monoclonal with the confirmation
of B phenotype except of two inadequate samples. One
case of ALCL was stated as polyclonal. One case of
CLL/SLL was stated as B-cell NHL and one as CLL/SLL.
SMZL was stated as a chronic lymphoproliferative dis-
ease. All of FCLs, MCLs and one high grade NHL were
classified as B-cell NHL. Fourteen out of sixteen (87.5%)
DLBCLs were classified as B-cell NHL. Two samples of
DLBCLs (12.5%) were inadequate for analysis. T-LBL was
classified as T-cell NHL and one ALCL was classified as poly-
clonal. Two out of five (40%) HLs were stated as polyclonal. In
three (60%) samples of HL predominance of CD4 positive lym-
phocytes (CD4+ CD8-) was found. CD4+CD8- result is not able
to distinguish malignant T-lymphocytes from benign reactive re-
sult (or in this cases lymphocyte background of HL). In the cases
of homogenous nodal lymphocyte proliferation with decreased
number of polyclonal B-lymphocytes, analysis of subpopulation
of T-lymphocytes is also usually preformed with a purpose of
finding a lymphocyte abnormalities. Six out of seven (85.7%)
benign lymphadenopathies were diagnosed as polyclonal and
one result suggested possibility of T-cell lymphoma.
Comparison of FNAC and FC diagnoses
Comparison between FNAC and FC diagnoses is sum-
marized in Table 5. In 26 patients diagnosed with some
type of NHL by FNAC, FC showed B-cell phenotype. In
one case stated as chronic lymphoproliferative disease by
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TABLE 4
COMPARISON OF FLOW CYTOMETRY (FC) ANALYSIS AND PATHOHISTOLOGICAL DIAGNOSIS
Pathohistological diagnosis
FC diagnosis CLL/SLL SMZL FCL MCL DLBCL T –LBL ALCL Hg NHL HL Benign Total
B-NHL 1 5 5 14 1 26
CLL/SLL 1 1
Chronic lymphoproliferative disease 1 1
T-NHL 1 1 2
CD4+CD8- 3 3
Polyclonal 1 2 6 9
Inadequate sample 2 2
Total 2 1 5 5 16 1 1 1 5 7 44
CLL/SLL – B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, SMZL – Splenic marginal zone B-cell lymphoma,
MALT – Marginal zone B-cell lymphoma of MALT type, FCL – Follicular lymphoma, MCL – Mantle cell lymphoma, DLBCL – Diffuse
large B-cell lymphoma, T-LBL – Precursor T-lymphoblastic lymphoma/leukemia, ALCL – Anaplastic large cell lymphoma, Hg NHL –
High grade non-Hodgkin’s lymphoma, HL – Hodgkin’s lymphoma, B-NHL – B-cell non Hodgkin’s Lymphoma, T-NHL – T-cell non-
-Hodgkin’s lymphoma, CD4+CD8- – predominance of CD4 positive lymphocytes, FC – flow cytometry
FNAC, FC correctly diagnosed it as CLL/SLL. In case of
SMZL (also pathohistologically verified) FC diagnosis
was chronic lymphoproliferative disease. Lymphoblastic
lymphoma was correctly classified by FC as T-cell NHL
(pathohistologically verified as T-LBL). In one case of
suspicious NHL (pathohistologically verified as benign)
FC suggested possibility of T-NHL. Predominance of
CD4 positive lymphocyte by FC was to one patient diag-
nosed as ALCL by FNAC (pathohistologically HL), to the
other patient suspicious of lymphoma by FNAC (pa-
thohistologically HL) and to the third patient HL by
FNAC (pathohistologically confirmed). In one patient cy-
tological diagnosis of the malignant tumor and differen-
tial diagnosis of lymphoma was established by FNAC;
and FC stated polyclonal result and pathohistological di-
agnosis was ALCL. Two patients diagnosed of HL by
FNAC that were pathohistologically confirmed were poly-
clonal by FC. Benign lymphadenopathies diagnosed by
FNAC were confirmed as polyclonal by FC. There were
two inadequate samples for FC; FNAC’s diagnoses were
NHL and malignant tumor and pathohistologically both
cases were diagnosed as DLBCL.
In one patient large B-cell NHL and in another small
cell NHL were diagnosed by the FNAC and immuno-
phenotype suggested MCL that was confirmed by the
pathohistology as shown in Table 3. Combined, FNAC
and FC improved sensitivity, positive predictive value,
negative predictive value and diagnostic accuracy (sensi-
tivity was 79.1%, specificity 85.7% and diagnostic accu-
racy 80%) as shown in Table 2.
Discussion and Conclusion
Our research showed that FNA and FC are comple-
mentary diagnostic procedures which play important
role in the process of diagnosing malignant lymphomas.
There was no case pathohistologically diagnosed as lym-
phoma that was diagnosed benign by the FNAC. Never-
theless, there was one case pathohistologically diagnosed
as benign that was stated by the FNAC as suspicious of
NHL. When analyzing accuracy of the FNAC according
to the suspicion of lymphoma or NHL and the differen-
tial diagnosis lymphoma, sensitivity was 97.7%, specific-
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TABLE 5
COMPARISON OF THE FINE-NEEDLE ASPIRATION CYTOLOGY (FNAC) AND FLOW CITOMETRY (FC) DIAGNOSIS
FC diagnosis




T-NHL CD4+CD8- Polyclonal Inadequate sample Total




Large B-cell NHL 12 12
LBL 1 1
ALCL 1 1
High grade NHL 1 1
Low grade NHL 2 2
Small cell NHL 2 2




Suspicious NHL 1 1




HL 1 2 3
Malignant tumor 1 1
Benign 6 6
Total 26 1 1 2 3 9 2 44
HL – Hodgkin’s lymphoma, B-NHL – B-cell non Hodgkin’s Lymphoma, T-NHL – T-cell non-Hodgkin’s lymphoma, CD4+CD8- – pre-
dominance of CD4 positive lymphocytes, CLL/SLL – B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, FCL – Fo-
llicular lymphoma, MCL – Mantle cell lymphoma, ALL – acute lymphoblastic leukemia, LBL – lymphoblastic lymphoma, ALCL –
Anaplastic large cell lymphoma, NHL – non-Hodgkin’s lymphoma, FNAC – fine needle aspiration cytology, FC – flow cytometry, SMZL
– Splenic marginal zone B-cell lymphoma
ity 85.7% and the diagnostic accuracy was 96%. When
analyzing accuracy of the FNAC according to the sub-
classification of lymphoma, sensitivity was 74.4%, speci-
ficity 85.7% and the diagnostic accuracy 76%. Combined,
FNAC and FC improved sensitivity, positive predictive
value, negative predictive value and the diagnostic accu-
racy. Sensitivity was 79.1% and diagnostic accuracy 80%
what is shown in Table 2.
In the case of FCL diagnosed as chronic lympho-
proliferative disease, pathohistological was graded I/II.
In the case of the DLBCL that the FNAC diagnosed as
FCL it was stated that it was FCL grade II/III. In one
case the diagnose of the DLBCL was not specified and in
one case it was incorrectly diagnosed as small cell NHL.
Pathohistologically diagnosed high grade lymphoma which
was stated by the FNAC as low grade, was interesting
case because bone marrow biopsy (pathohistologically
examined) showed infiltration with low grade lympho-
ma, suggesting that it was a case of disease transforma-
tion. In this case FNA failed to aspirate from the place of
transformation. Two similar cases described Nicol et al.
in their research14. Immunohystochemistry is an essen-
tial procedure for separating ALCL from metastatic car-
cinoma, melanoma and Hodgkin’s disease8. In the case of
HL diagnosed as ALCL by the FNAC, immunocytoche-
mistry failed and it was not diagnostic, so mistake was
highly possible. HL was correctly diagnosed by the FNAC
in 6 out of 8 (75%). Our result is lower than Jiménez-
-Heffernan et al.16. Their research was focused on the
value of the FNAC in the initial diagnosis of HL. Sensi-
tivity of their series was 82.4% (86.1% excluding non rep-
resentative cases). In the research of Chhieng et al.
60.7% biopsy-proven HLs were correctly diagnosed or
strongly suspected based on the cytological findings17.
Their study included 67.4% cases from primary tumors
and 32.6% were recurrent lesions. The only benign case
which was stated as suspicious of lymphoma was at first
pathohistologically diagnosed as possible B-cell lympho-
ma of MALT type, but that diagnosis was excluded by
further analysis (immunohistochemistry and PCR). Sen-
sitivity of the FNAC in the diagnosis of lymphoma (in-
cluding suspicion of lymphoma or NHL and differential
diagnosis lymphoma), was 97.7%. The result is similar to
one of Stewart et al. whose study showed sensitivity of
91%18. However in their study 27% of the patients with
recurrent lymphoma were accounted.
In the comparison of the pathohistological and FC di-
agnoses we found 2 out of 44 samples (4.5%) inadequate
for analysis. Inadequate and suspicious case rates in the
literature range from 4% to 30%6,7,14,15,19,20. Therefore
our findings are closer to lower part of the range. Both of
the inadequate samples were those pathohistologically
diagnosed as DLBCLs (FNAC diagnoses were NHL and
malignant tumor). The large neoplastic cells are often
disrupted during FNA and processing for flow cytometry
and then are usually markedly reduced or absent, in
comparison with their frequency on cytologic prepara-
tions21. In the one case of ALCL (diagnosed as malignant
tumor, differential diagnosis lymphoma) FC detected
polyclonal population of B lymphocytes in that sample.
Regarding to only one case of FC performed on ALCL
samples, it is not possible to conclude about its useful-
ness for those cases. Five out of eight samples diagnosed
as HL by the pathohistology were analyzed by the FC. FC
is not adequate method for diagnosing Hodgkin’s lym-
phoma because of the relative lack of neoplastic cells in
relation to background cells8. In our case, in three out of
five samples background cells showed predominance of
CD4+ lymphocytes and two samples presented poly-
clonal population of B lymphocytes. As stated earlier, FC
is not adequate method for diagnosing Hodgkin’s lym-
phoma. However, when lack of monoclonal B lympho-
cytes is found by FC in samples stated as suspicious of
lymphoma by FNAC, HL should be considered as differ-
ential diagnosis along with benign result. In one case of
the benign result (stated as suspicious of NHL) FC found
predominance of T lymphocytes and suggested possibil-
ity of T-cell lymphoma. Pathohistological analysis found
diffuse proliferation of small T lymphocytes (also sug-
gested possibility of B-cell lymphoma of MALT type) in
that sample but by further analysis the diagnosis of lym-
phoma was excluded.
Dong et al. evaluated a series of 139 confirmed lym-
phomas diagnosed using the FNAC with and without the
FC immunophenotyping analysis, including 60% cases in
which the primary diagnosis was represented. They eval-
uated the ability to positively diagnose lymphoma and
the frequency of cases that were accurately subclassi-
fied7. Cytomorphology coupled with FCM provided a de-
finitive diagnosis of lymphoma in 77% of the cases (82%
of NHL). In their study the accuracy rate was 67% with-
out FC suggesting great importance of FC in subclassifi-
cation of lymphomas. In the study of Meda et al. a defini-
tive diagnosis of NHL was made in 76.7% (158/206) of
the patients with lymphoma on the basis of combined
FNA and FC, including 72.3 (86/119) of primary lympho-
mas and 83% (72/87) of the previously diagnosed or re-
current lymphomas6. Young et al. reported their experi-
ence with the FNAC and the FC13. In their study defini-
tive diagnosis of NHL was made in 80% of their lym-
phoma cases on the basis of the FNA and FC, including
62% of primary lymphomas and 89% of previously diag-
nosed or recurrent lymphomas (with no need for histo-
logical sampling).
University Hospital Dubrava is rare case in Croatia
where FNAC and FC are situated at the same depart-
ment (Department of Clinical Cytology and Cytometry).
Considering clinical presentation and cytological find-
ings a cytologist indicates FC analysis with the purpose
of rationalizing use of monoclonal antibodies. It is impor-
tant to state FNAC and FC diagnoses are independent.
There is no influence of cytologist at FC diagnosis and
also biologist performing FC at FNAC result. This kind
of organization results with faster and more efficient
sample management what is important for fast and accu-
rate diagnosis. In that way clinicians are quickly pro-
vided with the required information.
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To summarize, in this study we have shown that the
FNAC and the FC are complementary methods which
play an important role in the process of diagnosing lym-
phoma. We have shown that these techniques can distin-
guish benign lymphadenopaties from lymphomas and
also subclassify lymphomas and quickly provide clini-
cians with that information.
R E F E R E N C E S
1. DAS DK, Diagn Cytopathol, 21 (1999) 240. — 2. DASKALOPOU-
LOU D, HARHALAKIS N, MAOUNI N, MARKIDOU SG, Acta Cytol, 39
(1995) 180. — 3. SÖDERLUND V, TANI E, SKOOG L, BAUER HC,
KREICBERGS A, Cytopathology, 12 (2001) 157. — 4. SWERDLOW SH,
CAMPO E, HARRIS NL, JAFFE ES, PILERI SA, STEIN H, THIELE J,
VARDIMAN JW (Eds) WHO classification of tumours of haematopoietic
and lymphoid tissues (IARC, Lyon 2008). — 5. SANDHAUS LM, Am J
Clin Pathol, 113 (2000) 623. — 6. MEDA BA, BUSS DH, WOODRUFF
RD, CAPPELLARI JO, RAINER RO, POWELL BL, GEISINGER KR, Am
J Clin Pathol, 113 (2000) 688. — 7. DONG HY, HARRIS NL, PREFFER
FI, PITMAN MB, Mod Pathol, 14 (2001) 472. — 8. YOUNG NA, AL-SA-
LEEM T, Cancer, 87 (1999) 325. — 9. GAGNETEN D, HIJAZI YM, JA-
FFE ES, SOLOMOND, Diagn Cytopathol, 14 (1996) 32. — 10. GALINDO
LM, HAVLIOGLU N, GROSSO LE, Diagn Cytopathol, 14 (1996) 253. —
11. SNEIGE N, DEKMEZIAN RH, KATZ RL, FANNING TV, LUKEMAN
JL, ORDOÑEZ NF, CABANILLAS FF, Acta Cytol, 34 (1990) 311. — 12.
DUNPHY CH, RAMOS R, Diagn Cytopathol, 16 (1997) 200. — 13.
YOUNG NA, AL-SALEEM TI, EHYA H, SMITH MR, Cancer, 84 (1998)
252. — 14. NICOL TL, SILBERMAN M, ROSENTHAL DL, BOROWITZ
MJ, Am J Clin Pathol, 114 (2000) 18. — 15. ZARDAWI IM, JAIN S, BE-
NNETT G, Diagn Cytopathol, 19 (1998) 274. — 16. JIMÉNEZ-HEFFE-
RNAN JA, VICANDI B, LÓPEZ-FERRER P, HARDISSON D, VIGUER
JM, Acta Cytol, 45 (2001) 300. — 17. CHHIENG DC, CANGIARELLA JF,
SYMMANS WF, COHEN JM, Cancer, 93 (2001) 52. — 18. STEWART CJ,
DUNCAN JA, FARQUHARSONM, RICHMOND J, J Clin Pathol, 51 (1998)
197. — 19. KALEEM Z, WHITE G, VOLLMER RT, Am J Clin Pathol, 115
(2001) 136. — 20. ZEPPA P, MARINO G, TRONCONE G, FULCINITI F,
DE RENZO A, PICARDI M, BENINCASA G, ROTOLI B, VETRANI A,
PALOMBINI L, Cancer, 102 (2004) 55. — 21. JORGENSEN JL, Cancer,
105 (2005) 443.
O. Jak{i}
Clinic of Internal Medicine, Department of Hematology, University Hospital Dubrava, Avenija Gojka [u{ka 6,
10 000 Zagreb, Croatia
e-mail: ojaksic@kbd.hr
TO^NOST ASPIRACIJSKE CITOLOGIJE I PROTO^NE CITOMETRIJE U PROCJENI NODALNIH I
EKSTRANODALIH SIJELA KOD PACIJENATA SA SUMNJOM NA LIMFOM
S A @ E T A K
Limfomi se danas dijagnosticiraju kombinacijom morfologije, imunofenotipa, genetskih zna~ajki i klini~ke slike,
tako da se uz samu citomorfolo{ku analizu u procesu dijagnosticiranja koriste i pomo}ne tehnike kao {to su citokemija,
imunocitokemija, molekularna dijagnostika i proto~na citometrija. Cilj na{eg istra`ivanja bio je utvrditi dijagnosti~ku
povezanost aspiracijske citologije i proto~ne citometrije te procijeniti mogu}nost tih metoda u dijagnosticiranju i sub-
klasifikaciji limfoma, pri ~emu je patohistologija slu`ila kao zlatni standard. Ova studija je retrospektivni pregled nala-
za pacijenata obra|enih u Klini~koj bolnici Dubrava zbog sumnje na limfom. Nakon analize, 50 pacijenata je zadovoljilo
kriterije uklju~ivanja u ovu studiju (dijagnoza postavljena na temelju aspiracijske citologije s ili bez proto~ne citometrije
te patohistolo{ka dijagnoza). Kod odre|ivanja to~nosti citologije u odnosu na postavljenu dijagnozu limfoma, non Hod-
gkinovog limfoma ili sumnje na limfom, osjetljivost je bila 97,7%, specifi~nost 85,7% i dijagnosti~ka to~nost 96%. Kod
odre|ivanja to~nosti citologije s obzirom na subklasifikaciju limfoma osjetljivost je bila 74,4%, specifi~nost 85,7% i dija-
gnosti~ka to~nost 76%. Kombinacija citologije s proto~nom citometrijom povisila je senzitivnost, pozitivnu prediktivnu
vrijednost, negativnu prediktivnu vrijednost i dijagnosti~ku to~nost. Senzitivnost je tada iznosila 79,1%, a dijagnosti~ka
to~nost 80%. Na{im istra`ivanjem pokazali smo da ove metode dobro razlikuju benigne limfadenopatije od limfoma, a
isto tako mogu i subklasificirati limfome te relativno brzo pru`iti potrebnu informaciju klini~aru.
P. [enjug et al.: The Accuracy of FNAC and FC in Lymphoma Diagnosing, Coll. Antropol. 34 (2010) 1: 131–137
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